|
Market Closed -
Oslo Bors
10:45:00 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 20.10 NOK | -0.50% |
|
+1.01% | -3.37% |
| 04-24 | Vistin Pharma ASA Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-24 | Vistin Pharma ASA, Q1 2026 Earnings Call, Apr 24, 2026 |
| Market Cap | 896M 95.06M 82.07M 76.99M 70.12M 132M 9.09B 134M 903M 354M 4.55B 357M 349M 15.15B | P/E 2024 |
16.7x | P/E 2025 | 12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 881M 93.48M 80.7M 75.71M 68.96M 130M 8.94B 131M 888M 348M 4.48B 351M 343M 14.9B | EV / Sales 2024 |
2.42x | EV / Sales 2025 | 2.01x |
| Free-Float |
41.06% | Yield 2024 |
5.27% | Yield 2025 | 7.21% |
Last Transcript: Vistin Pharma ASA
| 1 day | -0.50% | ||
| 1 week | +1.01% | ||
| Current month | -0.99% | ||
| 1 month | -2.43% | ||
| 3 months | -12.23% | ||
| 6 months | -4.29% | ||
| Current year | -3.37% |
| 1 week | 19.7 |  | 20.2 |
| 1 month | 19.65 | | 20.6 |
| Current year | 19.65 | | 23.5 |
| 1 year | 19.4 | | 24.4 |
| 3 years | 19.4 | | 28.8 |
| 5 years | 11.25 | | 28.8 |
| 10 years | 5 | | 29.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2023-12-31 | |
| Director of Finance/CFO | - | 2020-03-01 | |
Vegard Heggem
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Bettina Banoun
BRD | Director/Board Member | 54 | 2018-05-07 |
| Director/Board Member | - | 2016-12-31 | |
| Director/Board Member | 62 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/18/23 | Buy | Company | 100,000 | 0.2255% | ||
| 5/31/23 | Buy | Chief Executive Officer | 15,000 | 0.0338% | ||
| 5/30/23 | Buy | Director | 250,000 | 0.5638% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.50% | +1.01% | -16.60% | -13.36% | 94.89M | |
| -2.49% | -3.24% | +14.66% | +64.56% | 48.43B | |
| -0.12% | -5.43% | +52.28% | +115.90% | 39.72B | |
| -1.28% | -2.21% | -8.47% | +15.11% | 12.25B | |
| -0.33% | +1.55% | +14.43% | +72.12% | 11.84B | |
| -0.58% | -0.77% | +29.90% | +141.59% | 9.06B | |
| 0.00% | +1.64% | +22.99% | +39.94% | 7.57B | |
| -0.88% | +1.18% | +40.97% | -13.86% | 7.18B | |
| +0.46% | +2.19% | +13.91% | +192.06% | 6.84B | |
| +0.63% | -2.53% | -30.10% | +23.84% | 5.77B | |
| Average | -0.51% | +0.32% | +13.40% | +63.79% | 14.87B | |
| Weighted average by Cap. | -1.01% | -1.22% | +23.61% | +78.69% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 430M 45.58M 39.35M 36.92M 33.62M 63.22M 4.36B 64.1M 433M 170M 2.18B 171M 167M 7.26B | 452M 48M 41.44M 38.87M 35.41M 66.58M 4.59B 67.5M 456M 179M 2.3B 180M 176M 7.65B |
| Net income | 62.75M 6.66M 5.75M 5.39M 4.91M 9.24M 637M 9.36M 63.22M 24.78M 319M 25M 24.46M 1.06B | 74.75M 7.93M 6.85M 6.42M 5.85M 11M 758M 11.16M 75.32M 29.51M 380M 29.78M 29.14M 1.26B |
| Net Debt | -10.55M -1.12M -967K -907K -826K -1.55M -107M -1.57M -10.63M -4.17M -53.63M -4.2M -4.11M -178M | -14.91M -1.58M -1.37M -1.28M -1.17M -2.19M -151M -2.22M -15.02M -5.89M -75.78M -5.94M -5.81M -252M |
Employees
76
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-17 | NOK 20.10 | -0.50% | 1,402 |
| 26-08-14 | NOK 20.20 | +0.50% | 59,440 |
| 26-08-13 | NOK 20.10 | -0.50% | 7,028 |
| 26-08-12 | NOK 20.20 | 0.00% | 11,161 |
| 26-08-11 | NOK 20.20 | +1.51% | 3,832 |
- Stock Market
- Stocks
- VISTN Stock
Select your edition
All financial news and data tailored to specific country editions
